Novartis News News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Novartis news. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Novartis News Today - Breaking & Trending Today

Abbvie executive Patrick Horber appointed as Novartis's President, International

Basel: Novartis has announced that Marie-France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, has decided to leave the company and will step down from the. ....

Patrick Horber , University Of Zurich , Global Commercial Development , France Tschudin , Senior Vice President , Immunology Business Unit , Global Strategy , Global Commercial , Novartis News , Marie France Tschudin , Vas Narasimhan ,

Novartis gets positive CHMP opinion for Cosentyx in adults with hidradenitis suppurativa

Cosentyx is the first and only fully human biologic that directly inhibits interleukin-17A, an important cytokine involved in the inflammation of psoriatic arthritis, moderate to severe plaque. ....

Barry Mcgrath , Staedtisches Klinikum Dessau , Novartis Innovative Medicines International , European Commission , Drug Administration , European Hidradenitis Suppurativa Foundation , Brandenburg Medical School , Professor Christos , Founding Professor , Hidradenitis Suppurativa Clinical Response , Marie France Tschudin , Chief Commercial , Novartis News , Hidradenitis Suppurativa , Professor Christosc Zouboulis , Dr Barry Mcgrath ,

Novartis gets positive EMA panel opinion for prostate cancer drug Pluvicto

Pluvicto is a radioligand therapy combining a targeting compound (ligand, in this case directed to PSMA) with a therapeutic radioisotope ....

France General , Karim Fizazi , Gustave Roussy , Innovative Medicines International , European Commission , Medical Oncology , Marie France Tschudin , Chief Commercial Officer , Northern Ireland , Novartis News , Androgen Deprivation Therapy , Prostate Cancer , Prof Karim Fizazi ,

US Supreme Court turns down Novartis bid to block launch of multiple sclerosis drug Gilenya generics

Novartis settled with some of the drugmakers it had sued, allowing for some Gilenya generics before a key patent s 2027 expiration. ....

United States , Justice John Roberts , Aurobindo Pharma Ltd , Us Court , Drug Administration , Us Supreme Court On , Sun Pharmaceutical Industries Ltd , Supreme Court , Viatris Inc Mylan Pharmaceuticals , Apotex Inc , Pharm Co Ltd , India Based Aurobindo Pharma Ltd , Pennsylvania Based Viatris Inc , Mylan Pharmaceuticals , Canada Based Apotex , Federal Circuit , Novartis News , Multiple Sclerosis Drug , Multiple Sclerosis , Hec Pharm , Us Supreme Court , Patent Infringement , Aurobindo Pharma , Dr Reddys Labs , Sun Pharma , Mylan Pharma ,

Novartis to prioritise US market, unfazed by drug pricing pushback

Novartis aspire to "organically build its U.S. business to become a top-five player in the U.S. by 2027," it said in a statement. ....

United States , Joe Biden , Health Care , Swiss Exchange , Inflation Reduction Act , Novartis News , Partd Drugs , Vas Narasimhan ,